Breaking News Instant updates and real-time market news.

EXPE

Expedia

$98.34

-36.97 (-27.32%)

, GOOGL

Alphabet Class A

$1,307.02

16.9 (1.31%)

06:27
11/08/19
11/08
06:27
11/08/19
06:27

Expedia downgraded to Market Perform from Outperform at JMP Securities

JMP Securities analyst Andrew Boone downgraded Expedia (EXPE) to Market Perform from Outperform after its Q3 earnings miss and guidance cut. The analyst believes that the SEO issues revealed in the quarter will likely persist as a headwind to profitability and cash flow. Boone adds that Vrbo will require more time to benefit from rebranding. The analyst also expects Goolge's (GOOGL) vacation travel ad product and rental module to pose competitive threats to Expedia.

EXPE

Expedia

$98.34

-36.97 (-27.32%)

GOOGL

Alphabet Class A

$1,307.02

16.9 (1.31%)

  • 20

    Nov

  • 03

    Dec

  • 09

    Dec

EXPE Expedia
$98.34

-36.97 (-27.32%)

11/07/19
RHCO
11/07/19
NO CHANGE
Target $172
RHCO
Buy
Expedia price target lowered to $172 from $188 at SunTrust
SunTrust analyst Naved Khan lowered his price target on Expedia to $172 after its "sizable" Q3 EBITDA miss, with a decline in organic search traffic along with lower Average Daily Rates. The analyst is keeping his Buy rating however, stating that while SEO challenges will likely continue to hurt profitability in the near term, the company will look to offset the impact through "improved traffic conversion, product up-sell, and leaning more into brand and direct channels".
11/07/19
BOFA
11/07/19
DOWNGRADE
Target $129
BOFA
Neutral
Expedia downgraded to Neutral from Buy at BofA/Merrill
BofA Merrill Lynch analyst Justin Post downgraded Expedia (EXPE) to Neutral from Buy with a $129 price target, down from $160, after the company lowered its FY19 EBITDA growth guidance to 5-8% from 12%-15% citing Google (GOOGL) traffic changes, ADR pressures and payment transition issues. In addition to lowering his FY19 EBITDA estimate, Post also lowered his FY20 view, he noted.
11/07/19
11/07/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Twitter (TWTR) downgraded to Underperform from In Line at Evercore ISI with analyst Kevin Rippey citing his view that 2018 represented a period of "unsustainably high" margins as Twitter reaped the benefits of a period of sustained underinvestment. 2. Mylan (MYL) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst David Risinger sayinge has become more conservative in his estimates after competing U.S. generic businesses missed estimates in the past two days, which he thinks may be indicative of ongoing industry pressures. 3. Expedia (EXPE) downgraded to Neutral from Overweight at Piper Jaffray and to Neutral from Buy at DA Davidson and BofA/Merrill. 4. Bloomin' Brands (BLMN) downgraded to Neutral from Overweight at JPMorgan with analyst John Ivankoe citing valuation. 5. Papa John's (PZZA) downgraded to Neutral from Buy at MKM Partners with analyst Brett Levy saying the company has generated its first positive domestic comps in two years while laying the foundation for a "potential turnaround," but after a 43% run-up in the stock price since August 23, he believes the valuation warrants a neutral stance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/07/19
WELS
11/07/19
DOWNGRADE
WELS
Market Perform
Expedia downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo downgraded Expedia to Market Perform from Outperform.
GOOGL Alphabet Class A
$1,307.02

16.9 (1.31%)

11/04/19
SPHN
11/04/19
INITIATION
Target $12
SPHN
Overweight
Stephens starts Rubicon Project at Overweight with $12 price target
Stephens analyst Kyle Evans initiated coverage of Rubicon Project with an Overweight rating and $12 price target. He views the stock as "a smart way" to invest in the consolidation of programmatic ad spending at a reasonable valuation. He believes likely near-term catalysts of supply path optimization tailwinds and the likely success of its Demand Manager product outweigh risks of take rate pressure and the possibility that Google's (GOOGL) ad tech platform ends up spun-out or independent, Evans tells investors.
11/06/19
DADA
11/06/19
NO CHANGE
Target $20
DADA
Buy
Sonos rallies after DA Davidson calls 'natural acquisition target' for Apple
DA Davidson analyst Tom Forte reiterates a Buy rating on Sonos (SONO) with a $20 price target following Alphabet's (GOOG, GOOGL) acquisition of Fitbit (FIT). The stock in early trading is up 82c to $14.28. The analyst sees Sonos as the most likely company he covers to have its shares rally from either an improvement in investor perception or a takeover. Sonos is the "best house" on the "bad block" of hardware companies, and is "adjacent to the mansion on the neighboring block, Apple (AAPL)," Forte tells investors in a research note. Similar to Apple, Sonos makes products that are superior to the competition, has an eye for design, and boasts a premium brand that enables it to sell its products at higher prices than others, the analyst says. Further, Forte believes that similar to Fitbit not getting proper credit for its healthcare-related efforts, Sonos does not get credit for its superior technology and premium brand. As such, he sees Sonos as a "natural acquisition target for Apple." Furthermore, while less obvious than Apple, Amazon (AMZN) could acquire Sonos to advance its connected home efforts, according to Forte. The analyst also thinks the company could go private given the "lack of appreciation by Wall Street."
11/07/19
DADA
11/07/19
DOWNGRADE
Target $130
DADA
Neutral
Expedia downgraded to Neutral from Buy at DA Davidson
DA Davidson analyst Tom White downgraded Expedia (EXPE) to Neutral from Buy with a price target of $130, down from $162. The analyst cites the company's surprising Q3 earnings miss and a cut in its FY19 guidance, noting that the fundamental outlook for the stock has "significantly weakened" over the next several quarters. White further states that search engines are allocating "more prominent real estate to their own paid and monetizable travel search products", and sees "no demand source alternatives" that could mitigate Expedia's reliance on Google (GOOGL) any time soon.
11/07/19
PIPR
11/07/19
NO CHANGE
Target $39
PIPR
Neutral
TripAdvisor price target lowered to $39 from $52 at Piper Jaffray
Piper Jaffray analyst Michael Olson lowered his price target for TripAdvisor (TRIP) shares to $39 from $52 after the company reported weak Q3 revenue and EBITDA and lowered its FY19 EBITDA growth expectation. He believes Google's (GOOGL) "increased aggressiveness" in travel, including placing more emphasis on its own hotel offerings and driving free links farther down the page, is hurting TripAdvisor as well as other online travel players, Olson tells investors. TripAdvisor, and others, may have to turn to higher cost marketing channels to drive similar traffic or face further top-line challenges, contends the analyst, who keeps a Neutral rating on the TripAdvisor shares.

TODAY'S FREE FLY STORIES

FMCC

Freddie Mac

$0.00

(0.00%)

21:42
12/05/19
12/05
21:42
12/05/19
21:42
Initiation
Freddie Mac initiated at B. Riley FBR »

Freddie Mac initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDS

GDS Holdings

$47.16

1.88 (4.15%)

21:00
12/05/19
12/05
21:00
12/05/19
21:00
Syndicate
GDS Holdings 5.49M share Secondary priced at $45.50 »

JPMorgan, RBC Capital and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 12

    Dec

  • 06

    Dec

BIG

Big Lots

$19.17

-0.75 (-3.77%)

, GCO

Genesco

$36.94

0.38 (1.04%)

20:25
12/05/19
12/05
20:25
12/05/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

BIG

Big Lots

$19.17

-0.75 (-3.77%)

GCO

Genesco

$36.94

0.38 (1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 06

    Dec

UNVR

Univar

$23.15

0.22 (0.96%)

20:10
12/05/19
12/05
20:10
12/05/19
20:10
Hot Stocks
Univar to sell environmental sciences business to AEA Investors for $195M »

Univar announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLUG

Plug Power

$3.10

-0.195 (-5.93%)

20:04
12/05/19
12/05
20:04
12/05/19
20:04
Syndicate
Plug Power 40M share Secondary priced at $2.75 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

RGLD

Royal Gold

$117.91

0.64 (0.55%)

, TECK

Teck Resources

$15.71

-0.11 (-0.70%)

20:03
12/05/19
12/05
20:03
12/05/19
20:03
Hot Stocks
Royal Gold updates on Andacollo Workers Union ratifying 36-month collective deal »

Royal Gold (RGLD)…

RGLD

Royal Gold

$117.91

0.64 (0.55%)

TECK

Teck Resources

$15.71

-0.11 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

IR

Ingersoll-Rand

$128.95

1.405 (1.10%)

19:41
12/05/19
12/05
19:41
12/05/19
19:41
Upgrade
Ingersoll-Rand rating change at Wells Fargo »

Ingersoll-Rand upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICPT

Intercept

$119.86

2.42 (2.06%)

19:06
12/05/19
12/05
19:06
12/05/19
19:06
Hot Stocks
Intercept Phase 3 study for OCA in fibrosis patients published in The Lancet »

Intercept announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

HUN

Huntsman

$22.34

0.37 (1.68%)

18:52
12/05/19
12/05
18:52
12/05/19
18:52
Hot Stocks
Huntsman acquires Icynene-Lapolla for all-cash payment of $350M »

Huntsman announces its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

  • 18

    Dec

  • 19

    Dec

UBER

Uber

$28.65

-0.405 (-1.39%)

18:48
12/05/19
12/05
18:48
12/05/19
18:48
Hot Stocks
Uber: Non-consensual kissing of sexual body part reported in 1 in 3M U.S. trips »

Uber released its Safety…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBER

Uber

$28.65

-0.405 (-1.39%)

18:45
12/05/19
12/05
18:45
12/05/19
18:45
Hot Stocks
Uber says fatal physical assault reported in 1 in every 122M U.S. trips »

Uber released its Safety…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOMO

Domo

$19.47

-0.19 (-0.97%)

, EZPW

Ezcorp

$5.21

-0.01 (-0.19%)

18:44
12/05/19
12/05
18:44
12/05/19
18:44
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Domo…

DOMO

Domo

$19.47

-0.19 (-0.97%)

EZPW

Ezcorp

$5.21

-0.01 (-0.19%)

DOCU

DocuSign

$69.51

-0.465 (-0.66%)

ULTA

Ulta Beauty

$236.09

-3.27 (-1.37%)

ZUMZ

Zumiez

$30.63

0.67 (2.24%)

CLDR

Cloudera

$10.02

0.16 (1.62%)

MDLA

Medallia

$29.79

0.55 (1.88%)

CRWD

Crowdstrike

$53.00

-2.04 (-3.71%)

AOBC

American Outdoor Brands

$9.42

0.38 (4.20%)

YEXT

Yext

$16.62

0.065 (0.39%)

PD

PagerDuty

$24.99

-0.66 (-2.57%)

SAIC

SAIC

$83.82

-0.57 (-0.68%)

ZM

Zoom Video

$69.73

-0.22 (-0.31%)

KFY

Korn/Ferry

$40.26

0.39 (0.98%)

COO

Cooper Companies

$313.10

1 (0.32%)

GWRE

Guidewire

$119.32

0.68 (0.57%)

OKTA

Okta

$119.18

-2.64 (-2.17%)

UBER

Uber

$28.65

-0.405 (-1.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 12

    Dec

  • 12

    Dec

  • 13

    Dec

  • 16

    Dec

  • 17

    Dec

  • 17

    Dec

UBER

Uber

$28.65

-0.405 (-1.39%)

18:43
12/05/19
12/05
18:43
12/05/19
18:43
Hot Stocks
Uber says 107 total fatalities in 2017-2018 reported in relation to Uber app »

Uber released its Safety…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBER

Uber

$28.65

-0.405 (-1.39%)

18:34
12/05/19
12/05
18:34
12/05/19
18:34
Periodicals
Breaking Periodicals news story on Uber »

Uber reports 3,000 sexual…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMG

Chipotle

$819.61

10.12 (1.25%)

18:33
12/05/19
12/05
18:33
12/05/19
18:33
Hot Stocks
Chipotle CEO: I took time to understand what makes us unique »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$26.02

0.36 (1.40%)

18:17
12/05/19
12/05
18:17
12/05/19
18:17
Hot Stocks
Rent-A-Center raises quarterly dividend to 29c from 25c per share »

The dividend will be paid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKH

Black Hills

$76.66

0.01 (0.01%)

18:02
12/05/19
12/05
18:02
12/05/19
18:02
Hot Stocks
Black Hills utilities receive approval to upsize Renewable Ready program »

Black Hills announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRIM

Primoris

$21.92

0.3 (1.39%)

18:02
12/05/19
12/05
18:02
12/05/19
18:02
Hot Stocks
Primoris awarded two pipeline contracts for over $45M »

Primoris Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMAT

LeMaitre

$35.94

-0.09 (-0.25%)

18:01
12/05/19
12/05
18:01
12/05/19
18:01
Hot Stocks
LeMaitre CFO sells 121K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLBK

Columbia Financial

$16.33

-0.24 (-1.45%)

18:01
12/05/19
12/05
18:01
12/05/19
18:01
Hot Stocks
Columbia Financial expands stock buyback to acquire additional 3M shares »

Columbia Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXS

Axis Capital

$58.42

0.31 (0.53%)

17:49
12/05/19
12/05
17:49
12/05/19
17:49
Hot Stocks
Axis Capital increases quarterly dividend 2.5% to 41c per share »

Axis Capital has declared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

PZZA

Papa John's

$59.67

-0.53 (-0.88%)

17:48
12/05/19
12/05
17:48
12/05/19
17:48
Periodicals
Former Papa John's CEO files suit against ad firm, Bloomberg says »

Papa John's founder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 18

    Dec

THG

Hanover Insurance

$133.80

0.52 (0.39%)

17:47
12/05/19
12/05
17:47
12/05/19
17:47
Hot Stocks
Hanover Insurance raises dividend to 65c/shr, announces $2.50 special dividend »

The Hanover Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

BHVN

Biohaven Pharmaceutical

$53.79

-0.235 (-0.44%)

17:46
12/05/19
12/05
17:46
12/05/19
17:46
Hot Stocks
Biohaven Pharmaceutical issued patent relating to troriluzole »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPZM

Epizyme

$15.32

-0.48 (-3.04%)

17:45
12/05/19
12/05
17:45
12/05/19
17:45
Upgrade
Morgan Stanley upgrades Epizyme to Overweight ahead of lymphoma data »

Morgan Stanley analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 18

    Dec

  • 23

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.